EMA Approves First Gene Therapy for Beta Thalassemia 9-01-2024
The European Medicines Agency (EMA) has recently recommended the approval of the first therapy based in CRISPR/Cas9, a groundbreaking gene-editing technology that earned its inventors the Nobel Prize in 2020.…